(1)
Treat-to-Target (T2T) of Serum Urate (SUA) in Gout: A Clinical Audit in Real-World Gout Patients. Reumatismo 2019, 71 (3), 154-159. https://doi.org/10.4081/reumatismo.2019.1225.